IGF-1 increases BRCA1 gene expression and enhances BRCA1 promoter activity, indicating a complex, bidirectional interplay between IGF-1 pathways and BRCA1-mediated tumor protective pathways [97]. The gene discussed is IGF1; the disease is neoplasm.